Translation of survival benefits observed in glioblastoma clinical trials to populations and to
longer-term survival remains uncertain. We aimed to assess if≥ 2-year survival has …

Despite the rapid incorporation of the current standard treatment in clinical practice and the
thereby achieved modest survival gain at the population-level, prevailing POC needs to be …

The molecular classification of glioblastoma (GBM) based on gene expression might better
explain outcome and response to treatment than clinical factors. Whole transcriptome …

Background Glioblastoma is the most frequent primary malignant brain tumor. In daily
practice and at whole country level, oncological care management for glioblastoma patients …

Abstract Background Long non-coding RNAs (lncRNAs) have been considered as one type
of gene expression regulator for cancer development, but it is not clear how these are …

Abstract Treatment for glioblastoma (GBM) includes surgical resection and adjuvant
radiotherapy (RT) and chemotherapy. The optimal time interval between surgery and RT …

OBJECT There are few and conflicting reports on the effects of delayed initiation of
chemoradiotherapy on the survival of patients with glioblastoma. The standard of care for …

Molecular targets for the pathological vasculature are the vascular endothelial growth factor
(VEGF)/VEGF receptor axis, integrins, angiopoietins, and platelet-derived growth factor …

Background This study assessed the effects of single or combined administration of
temozolomide (TMZ) and interferon-gamma (IFN-ᵞ) on anxiety-like behaviors, balance …

Introduction To assess the management of immunocompetent patients with primary central
nervous system lymphomas (PCNSL) in Spain. Methods Retrospective analysis of 327 …